Multiple human papillomavirus infection: Don't forget the genetic background

Journal of Infectious Diseases

Volumn 204, Issue 11, 2011, Pages 1816-

  Cervantes, Jorge L ^a  

^a UNIVERSITY OF CONNECTICUT   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

HLA ANTIGEN CLASS 2; NEUTRALIZING ANTIBODY; WART VIRUS VACCINE;

ALLELE; CROSS PROTECTION; ETHNICITY; HUMAN; HUMAN PAPILLOMAVIRUS TYPE 16; HUMAN PAPILLOMAVIRUS TYPE 18; HUMAN PAPILLOMAVIRUS TYPE 31; HUMAN PAPILLOMAVIRUS TYPE 33; HUMAN PAPILLOMAVIRUS TYPE 45; HUMAN PAPILLOMAVIRUS TYPE 6; LETTER; MIXED INFECTION; PAPILLOMAVIRUS INFECTION; PREVALENCE; PRIORITY JOURNAL;

CERVIX UTERI; FEMALE; HUMANS; PAPILLOMAVIRIDAE; PAPILLOMAVIRUS INFECTIONS; UTERINE CERVICAL NEOPLASMS;

EID: 80155188619     PISSN: 00221899     EISSN: None     Source Type: Journal    
DOI: 10.1093/infdis/jir626     Document Type: Letter

References (10)

1. Plummer M, Vaccarella S, Franceschi S. Multiple human papillomavirus infections: The exception or the rule? J Infect Dis 2011; 203:891-3.
2. Chaturvedi AK, Katki HA, Hildesheim A, et al. Human papillomavirus infection with multiple types: Pattern of coinfection and risk of cervical disease. J Infect Dis 2011; 203: 910-20.
3. Lazcano-Ponce E, Herrero R, Munoz N, et al. Epidemiology of HPV infection among Mexican women with normal cervical cytology. Int J Cancer 2001; 91:412-20.
4. Sebbelov AM, Davidson M, Kruger Kjaer S, et al. Comparison of human papillomavirus genotypes in archival cervical cancer specimens from Alaska natives, Greenland natives and Danish Caucasians. Microbes Infect 2000; 2:121-6.
5. Cervantes J, Lema C, Valentina Hurtado L, et al. HLA-DRB1*1602 allele is positively associated with HPV cervical infection in Bolivian Andean women. Hum Immunol 2003; 64:890-5.
6. Touze A, de Sanjose S, Coursaget P, et al. Prevalence of anti-human papillomavirus type 16, 18, 31, and 58 virus-like particles in women in the general population and in prostitutes. J Clin Microbiol 2001; 39: 4344-8.
7. Camargo M, Soto-De Leon SC, Sanchez R, Perez-Prados A, Patarroyo ME, Patarroyo MA. Frequency of human papillomavirus infection, coinfection, and association with different risk factors in Colombia. Ann Epidemiol 2011; 21:204-13.
8. Smith MA. Occurrence, determinants and dynamics of HPV coinfections in a cohort of Montreal university students. In: Department of community health and epidemiology. Kingston, Ontario, Canada: Queen's University, 2011:144.
9. No JH, Kim MK, Jeon YT, Kim YB, Song YS. Human papillomavirus vaccine: Widening the scope for cancer prevention. Mol Carcinog 2011; 50:244-53.
10. Cervantes J, Sonoda S. HLA-based human papillomavirus epitope prediction. In 7th Asia-Oceania Histocompatibility Workshop and Congress. Karuizawa, Japan, 2004. MHC 10:201-202. (in ). http://www.medicalonline.jp